|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Breast cancer
Short-term Impact of Hormone Replacement Therapy on Risk of Breast Cancer in
BRCA
Mutation Carriers: A Nationwide Study in South Korea
Hye Yeon Kim, Jisoo Park, Seok Joo Moon, Sohyeon Jeong, Jin Hwa Hong, Jae Kwan Lee, Geum Joon Cho, Hyun-Woong Cho
Cancer Res Treat.
2024;56(1):143-148. Published online August 16, 2023 DOI:
https://doi.org/10.4143/crt.2023.653
Crossref 1
Real-World Clinical Data of Palbociclib in Asian Metastatic Breast Cancer Patients: Experiences from Eight Institutions
Jieun Lee, Hyung Soon Park, Hye Sung Won, Ji Hyun Yang, Hee Yeon Lee, In Sook Woo, Kabsoo Shin, Ji Hyung Hong, Young Joon Yang, Sang Hoon Chun, Jae Ho Byun
Cancer Res Treat.
2021;53(2):409-423. Published online October 28, 2020 DOI:
https://doi.org/10.4143/crt.2020.451
Web of Science 13
Crossref 12
Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor–Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors
Koung Jin Suh, Se Hyun Kim, Kyung-Hun Lee, Tae-Yong Kim, Yu Jung Kim, Sae-Won Han, Eunyoung Kang, Eun-Kyu Kim, Kidong Kim, Jae Hong No, Wonshik Han, Dong-Young Noh, Maria Lee, Hee Seung Kim, Seock-Ah Im, Jee Hyun Kim
Cancer Res Treat.
2017;49(4):1153-1163. Published online February 27, 2017 DOI:
https://doi.org/10.4143/crt.2016.463
Web of Science 9
Crossref 7
Survival Outcome of Combined GnRH Agonist and Tamoxifen Is Comparable to That of Sequential Adriamycin and Cyclophosphamide Chemotherapy Plus Tamoxifen in Premenopausal Patients with Lymph-Node–Negative, Hormone-Responsive, HER2-Negative, T1-T2 Breast Cancer
Guiyun Sohn, Sei Hyun Ahn, Hee Jeong Kim, Byung-Ho Son, Jong Won Lee, Beom Seok Ko, Yura Lee, Sae Byul Lee, Seunghee Baek
Cancer Res Treat.
2016;48(4):1351-1362. Published online April 6, 2016 DOI:
https://doi.org/10.4143/crt.2015.444
Web of Science 7
Crossref 6
Ovarian Ablation Using Goserelin Improves Survival of Premenopausal Patients with Stage II/III Hormone Receptor-Positive Breast Cancer without Chemotherapy-Induced Amenorrhea
Juan Zhou, San-Gang Wu, Jun-Jie Wang, Jia-Yuan Sun, Feng-Yan Li, Qin Lin, Huan-Xin Lin, Zhen-Yu He
Cancer Res Treat.
2015;47(1):55-63. Published online August 21, 2014 DOI:
https://doi.org/10.4143/crt.2013.165
Web of Science 7
Crossref 6
Effects of the Expression of Leptin and Leptin Receptor (OBR) on the Prognosis of Early-stage Breast Cancers
Yongnam Kim, Si-Young Kim, Jae Jin Lee, Jeongho Seo, Youn-Wha Kim, Suck Hwan Koh, Hwi-Joong Yoon, Kyung Sam Cho
Cancer Res Treat.
2006;38(3):126-132. Published online June 30, 2006 DOI:
https://doi.org/10.4143/crt.2006.38.3.126
Crossref 11
Relation between Body Size and Body Mass Index and Breast Cancer by Menopausal Status in Korea
Se Hyun Ahn, Mi Kyung Kim, Suk Il Kim
J Korean Cancer Assoc.
1999;31(1):72-81.
Comparison of Risk Factor in Breast Cancer Patients by Menopausal Status
Woo Suk Kim, Koo Jeong Kang, You Sah Kim
J Korean Cancer Assoc.
1996;28(5):829-835.
1
Journal Impact Factor 4.6
> Browse Articles > Search
